Table 1.

Potential Advantages of Continuous Subcutaneous Insulin Infusion (Insulin Pump Therapy) when compared to Multiple-Dose Insulin Injections.

Programmable insulin delivery allows closer match with physiologic needs

Uses only short- or rapid-acting insulin, minimizing peaks and absorption-related variability

Uses one injection site for up to 72 h, thus reducing variations in absorption and treatment-related burden from multiple injections

Reduction in glycemic variability and improved glycemic control

Decreased risk of severe hypoglycemia and need for emergent medical attention

Reduction in need for hospitalization and cost of care

Improved quality of life and treatment satisfaction